LP
Ligand Pharmaceuticals Inc disclosed a 49.9% stake in PTHS
Ligand Pharmaceuticals Inc reported owning 49.9% of Pelthos Therapeutics Inc. (PTHS) (5,189,177 shares) in a Schedule 13D filed Nov 4, 2026.
A 13D means the holder may push for changes at the company.
- Disclosed
- Nov 4, 2026
- Source
- Schedule 13D